Laurus Labs (Large Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Laurus Labs Limited |
|||
|
Price: ₹559.20 | ||
| 52 Week Low: ₹360.85 52 Week High: ₹593.00 |
|||
| Market Capital: 26,076.42 Crore (Largecap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Laurus Labs Share Price Target For 2024
- 1.1.1: Laurus Labs Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Laurus Labs Share Price Target For 2025
- 1.2.1: Laurus Labs Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Laurus Labs Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Laurus Labs Brief Company Overview
- 4: Laurus Labs Financial Performance
- 4.0.1: Is Laurus Labs A Good Buy For Long Term?
To predict the Laurus Labs's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Laurus Labs Share Price Target For 2024
The line chart displays the monthly closing prices of Laurus Labs with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Laurus Labs shares in 2024, see the table below.
Laurus Labs Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 577.45 (+3.26%) | Fibonacci Extension Level 50.00% |
| 2024 Target 2 | 571.65 (+2.22%) | Price Action: 03 Dec 2024 Low |
| 2024 Target 1 | 565.85 (+1.18%) | Price Action: 18 Dec 2024 Low |
| Current Price | 559.20 | Laurus Labs's share price as of 20 Dec 2024 |
| Stop Loss 1 | 555.0 (-0.76%) | Price Action: 27 Nov 2024 High |
| Stop Loss 2 | 549.28 (-1.78%) | Price Action: Dec 2021 High |
| Stop Loss 3 | 543.13 (-2.88%) | Fibonacci Retracement Level 28.20% |
Short-Term Technical Outlook
Current Technical Position: Laurus Labs is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹552.72 serves as the nearest technical reference point.
Historical Returns: 3-month: +20.72% | 6-month: +31.82% | 1-year: +30.22%
Laurus Labs Share Price Target For 2025
The line chart displays the monthly closing prices of Laurus Labs with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Laurus Labs shares in 2025, see the table below.
Laurus Labs Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 729.78 (+30.50%) | Price Action: Chart |
| 2025 Target 2 | 716.17 (+28.07%) | Price Action: Chart |
| 2025 Target 1 | 709.08 (+26.80%) | Fibonacci Extension Level 64.90% |
| Current Price | 559.20 | Laurus Labs's share price as of 20 Dec 2024 |
| Stop Loss 1 | 520.81 (-6.87%) | Price Action: May 2021 High |
| Stop Loss 2 | 513.94 (-8.10%) | Technical Indicator: MA50 |
| Stop Loss 3 | 507.96 (-9.17%) | Price Action: May 2022 Low |
Long-Term Technical Outlook
52-Week Range Analysis: Laurus Labs is currently trading near its 52-week high of ₹593, showing strong yearly momentum.
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +30.22% | 3-year: +4.85% | 5-year: +703.68%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Laurus Labs Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹559.20 | ||
| 2024 | ₹504.87 | -9.72% | ₹512.44 |
| 2025 | ₹646.02 | +27.96% | ₹655.71 |
| 2026 | ₹774.65 | +19.91% | ₹786.27 |
| 2027 | ₹887.61 | +14.58% | ₹900.92 |
| 2028 | ₹995.52 | +12.16% | ₹1,010.45 |
| 2029 | ₹1,117.76 | +12.28% | ₹1,134.53 |
| 2030 | ₹1,277.04 | +14.25% | ₹1,296.61 |
| 2031 | ₹1,407.67 | +10.23% | ₹1,428.79 |
| 2032 | ₹1,511.04 | +7.34% | ₹1,533.71 |
| 2033 | ₹1,608.62 | +6.46% | ₹1,632.75 |
| 2034 | ₹1,730.66 | +7.59% | ₹1,781.13 |
| 2035 | ₹1,908.06 | +10.25% | ₹1,942.63 |
| 2036 | ₹2,040.68 | +6.95% | ₹2,071.29 |
| 2037 | ₹2,134.47 | +4.60% | ₹2,166.49 |
| 2038 | ₹2,221.72 | +4.09% | ₹2,265.64 |
| 2039 | ₹2,306.99 | +3.84% | ₹2,427.14 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Laurus Labs Brief Company Overview
Laurus Labs Limited: Leading Pharma Innovator with Global Reach Laurus Labs Limited, founded in 2005, is an Indian pharmaceutical giant with a strong international presence. The company has a diverse product range, focusing on: APIs and advanced...
intermediates for critical therapeutic areas Oral solid formulations Contract development and manufacturing services Specialty ingredients for nutraceuticals and cosmeceuticals Enzymatic solutions for industrial biotechnology Laurus Labs has built a reputation for innovation, quality, and customer focus in the industry. The company's commitment to R&D has led to a significant patent portfolio, solidifying its position as a thought leader.Laurus Labs Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 26,076.42 Crore | Market valuation of Laurus Labs's shares. |
| Revenue (TTM) | 5,053.19 Crore | Total revenue generated by Laurus Labs over the past twelve months. |
| Net Income (TTM) | +1,311,000,064.00 | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +5.78% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +2.59% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-0.10% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
-46.30% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
67.3 | Company's total debt divided by total shareholder equity. |
| Total Debt | 2,789.03 Crore | Sum of Laurus Labs's current & long-term financial obligations. |
| Total Cash | 44.92 Crore | Total amount of liquid funds available to Laurus Labs. |
| Beta | 1.11 | Beta is greater than 1 indicating that the Laurus Labs's price is more volatile than the market. |
Is Laurus Labs A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
